VEGFA and renal cell carcinoma: His past medical history included renal cell carcinoma (RCC) with left nephrectomy (7 months before admission) on combined therapy with axitinib (tyrosine kinase inhibitor–anti-VEGF) and an ICPI pembrolizumab administered intravenously every 3 weeks.